"The scientist" traces the life trajectory of Prof. Dr. h. c. Rapahel Mechoulam, considered by many as the biggest name on the subject in the world

The potential of cannabis and cannabinoids for the treatment of post-traumatic stress disorder is a growing area of research. An increasing number of people have reported benefits from using cannabis products to alleviate the symptoms of the disease.

According to researchers' findings, cannabis use was associated with higher levels of physical activity

Columnist Paulo Jordão challenges himself, based on data collected from relevant sources, to measure the Cannabis market in Brazil.

Many users believe that a regular dose of CBD helps improve focus and motivation, making it easier to tackle workloads.

The plaintiffs argue that the federal status of cannabis violates their civil and constitutional liberties, as well as their freedom to travel within the country.

The theory that Cannabis may help reduce opioid dependence is gaining more support

Cannabis Fair 2026, taking place from May 21 to 23 in São Paulo, will bring together companies, researchers, and investors, highlighting the industrial, technological, and regulatory advancements of cannabis in Brazil

New resolution allows planting by universities and pharmaceutical industries, requiring maximum security systems and total traceability of the plant

Proposal aims to regulate the performance of non-profit entities in a controlled experimental environment, using the Regulatory Sandbox model to comply with STJ decision

A new study with autistic adults shows that the use of cannabis can quickly reduce sensory, emotional, and behavioral symptoms, pointing to potential immediate relief

How the pharmaceutical industry ensures quality and safety in cannabis-based products sold in Brazil

There is currently no evidence that cannabis use directly interferes with the action of antibiotics, but experts recommend caution and medical supervision during treatment.

For Fritz Eduardo Kasbaum the scientific ecosystem is ready to expand, but still depends on changes in national regulation

Event in São Paulo brings together regulators and experts to discuss regulation, cultivation, and the market landscape of the sector

First Section's trial will take place on Thursday (06); decision impacts cannabis regulation in the country

Director-General of the National Narcotics Fund of Colombia, Milver Rojas, states that the process will be immediate once Anvisa confirms and foresees a return to the four to five-day deadline for each authorization

Institutions like UEL and UEM strengthen scientific research and dialogue with society to demystify the therapeutic use of the plant and influence public policies

Province approves adherence to national law and prepares the ground to boost therapeutic access, research, and new productive opportunities